Michaela Týblová

3.8k total citations
37 papers, 1.3k citations indexed

About

Michaela Týblová is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Michaela Týblová has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 13 papers in Rheumatology and 11 papers in Neurology. Recurrent topics in Michaela Týblová's work include Multiple Sclerosis Research Studies (26 papers), Systemic Lupus Erythematosus Research (9 papers) and Peripheral Neuropathies and Disorders (6 papers). Michaela Týblová is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Systemic Lupus Erythematosus Research (9 papers) and Peripheral Neuropathies and Disorders (6 papers). Michaela Týblová collaborates with scholars based in Czechia, United States and Italy. Michaela Týblová's co-authors include Eva Havrdová, Dana Horáková, Jan Krásenský, Manuela Vaněčková, Zdeněk Seidl, Robert Zivadinov, Niels Bergsland, Tomáš Uher, Tomáš Kalinčík and Michael G. Dwyer and has published in prestigious journals such as PLoS ONE, Neurology and The Lancet Neurology.

In The Last Decade

Michaela Týblová

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela Týblová Czechia 21 949 347 337 256 164 37 1.3k
Leonora Fisniku United Kingdom 9 1.2k 1.2× 398 1.1× 432 1.3× 166 0.6× 182 1.1× 14 1.3k
Dina Jacobs United States 21 970 1.0× 408 1.2× 625 1.9× 288 1.1× 159 1.0× 48 2.2k
S. Anand Trip United Kingdom 17 1.2k 1.2× 386 1.1× 430 1.3× 222 0.9× 306 1.9× 34 1.8k
Shahamat Tauhid United States 23 975 1.0× 223 0.6× 372 1.1× 399 1.6× 287 1.8× 60 1.5k
Aaron Boster United States 22 925 1.0× 207 0.6× 405 1.2× 306 1.2× 168 1.0× 44 1.4k
Francisco Pérez‐Miralles Spain 20 910 1.0× 261 0.8× 445 1.3× 198 0.8× 78 0.5× 60 1.3k
Luisa Caniatti Italy 19 662 0.7× 335 1.0× 454 1.3× 228 0.9× 76 0.5× 35 1.4k
Kryshani Fernando United Kingdom 14 967 1.0× 320 0.9× 434 1.3× 130 0.5× 236 1.4× 18 1.2k
Irena Dujmović Serbia 23 1.0k 1.1× 389 1.1× 656 1.9× 279 1.1× 96 0.6× 65 1.6k
Caspar F. Pfueller Germany 22 902 1.0× 236 0.7× 353 1.0× 124 0.5× 248 1.5× 30 1.5k

Countries citing papers authored by Michaela Týblová

Since Specialization
Citations

This map shows the geographic impact of Michaela Týblová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Týblová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Týblová more than expected).

Fields of papers citing papers by Michaela Týblová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Týblová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Týblová. The network helps show where Michaela Týblová may publish in the future.

Co-authorship network of co-authors of Michaela Týblová

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Týblová. A scholar is included among the top collaborators of Michaela Týblová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Týblová. Michaela Týblová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tichopád, Aleš, Jana Junkerová, Michala Jakubíková, et al.. (2024). Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry. Neurology and Therapy. 14(1). 227–242.
2.
Nytrová, Petra, et al.. (2023). Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab. Frontiers in Immunology. 14. 1149629–1149629. 5 indexed citations
3.
Týblová, Michaela. (2023). Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis. Česká a slovenská neurologie a neurochirurgie. 86/119(3).
4.
Jakubíková, Michala, Michaela Týblová, Iveta Nováková, et al.. (2021). Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. European Journal of Neurology. 28(10). 3418–3425. 52 indexed citations
5.
Bergsland, Niels, Dana Horáková, Michael G. Dwyer, et al.. (2017). Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study. NeuroImage Clinical. 17. 444–451. 59 indexed citations
6.
Uher, Tomáš, Eva Havrdová, Lukáš Sobíšek, et al.. (2016). Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?. Multiple Sclerosis Journal. 23(2). 242–252. 34 indexed citations
7.
Jakubíková, Michala, Jiří Piťha, Helena Marečková, et al.. (2015). Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells. Journal of the Neurological Sciences. 358(1-2). 101–106. 7 indexed citations
8.
Browne, Richard W., B. Weinstock‐Guttman, Dana Horáková, et al.. (2014). Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. Journal of Neurology Neurosurgery & Psychiatry. 85(8). 859–864. 37 indexed citations
9.
Uher, Tomáš, Dana Horáková, Niels Bergsland, et al.. (2014). Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. Journal of Neurology. 261(9). 1735–1744. 41 indexed citations
10.
Zivadinov, Robert, Dana Horáková, Niels Bergsland, et al.. (2014). Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study. Journal of Neuroimmunology. 273(1-2). 58–64. 22 indexed citations
11.
Uher, Tomáš, Ralph H. B. Benedict, Dana Horáková, et al.. (2014). Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment. Journal of the Neurological Sciences. 347(1-2). 229–234. 9 indexed citations
12.
Uher, Tomáš, Dana Horáková, Niels Bergsland, et al.. (2014). MRI correlates of disability progression in patients with CIS over 48 months. NeuroImage Clinical. 6. 312–319. 32 indexed citations
13.
Kalinčík, Tomáš, Charles R.G. Guttmann, Jan Krásenský, et al.. (2013). Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome. Genes and Immunity. 14(4). 244–248. 17 indexed citations
14.
Zivadinov, Robert, Eva Havrdová, Niels Bergsland, et al.. (2013). Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis. Radiology. 268(3). 831–841. 132 indexed citations
15.
Weinstock‐Guttman, Bianca, Robert Zivadinov, Dana Horáková, et al.. (2013). Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event. Journal of Neurology Neurosurgery & Psychiatry. 84(11). 1186–1191. 109 indexed citations
16.
Weinstock‐Guttman, Bianca, Dana Horáková, Robert Zivadinov, et al.. (2013). Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes. Journal of Neuroimmunology. 263(1-2). 121–127. 12 indexed citations
17.
Kalinčík, Tomáš, Manuela Vaněčková, Michaela Týblová, et al.. (2012). Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study. PLoS ONE. 7(11). e50101–e50101. 66 indexed citations
18.
Horáková, Dana, Robert Zivadinov, Bianca Weinstock‐Guttman, et al.. (2011). HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. Journal of Neuroimmunology. 236(1-2). 76–80. 14 indexed citations
19.
Jager, Philip L. De, Lori B. Chibnik, Jing Cui, et al.. (2009). Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. The Lancet Neurology. 8(12). 1111–1119. 186 indexed citations
20.
Štěpán, J, Eva Havrdová, Michaela Týblová, et al.. (2004). Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clinica Chimica Acta. 348(1-2). 147–154. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonora Fisniku Breakdown of academic impact, for papers by Dina Jacobs Breakdown of academic impact, for papers by S. Anand Trip Breakdown of academic impact, for papers by Shahamat Tauhid Breakdown of academic impact, for papers by Aaron Boster Breakdown of academic impact, for papers by Francisco Pérez‐Miralles Breakdown of academic impact, for papers by Luisa Caniatti Breakdown of academic impact, for papers by Kryshani Fernando Breakdown of academic impact, for papers by Irena Dujmović Breakdown of academic impact, for papers by Caspar F. Pfueller
Rankless by CCL
2026